Advisor Group Holdings, Inc. Baudax Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.26 - $0.87 $67 - $224	-258 Reduced 21.5%	942 $0
Q1 2022 May 04, 2022	BUY	$1.58 - $8.47 $1,896 - $10,164	1,200 New	1,200 $2,000

Ticker BXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,003,700
Market Cap $200K
Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.